Issam Awad

Biomarkers of Cerebral Cavernous Angioma with Symptomatic Hemorrhage (CASH)

National Institute of Neurological Disorders and Stroke · R01

Contact PI · $3.4M · University of Chicago

Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

National Institute of Neurological Disorders and Stroke · R01

Contact PI · $3.9M · University of Chicago

Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis

National Institute of Neurological Disorders and Stroke · P01

Project lead · $3.1M · Duke University

Trial Readiness in Cavernous Angiomas with Symptomatic Hemorrhage

National Institute of Neurological Disorders and Stroke · U01

Contact PI · $3.8M · University of Chicago

Biomarkers of CASH

Principal investigator · Active not recruiting

University of Chicago

CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

Principal investigator · Completed

University of Chicago

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Principal investigator · Completed · Phase 3

Johns Hopkins University

Modifiers of Disease Severity in Cerebral Cavernous Malformations

Principal investigator · Completed

University of California, San Francisco